drugset / Trial / NCT06082869

Evaluation and Comparison of a Novel Dentrifice Formulation on Plaque Removal

NCT06082869 ↗

Phase 0 Completed 82 enrolled Protegera, Inc.
RandomizedParallel-groupDouble-blindPrevention

Summary

To evaluate and compare plaque removal efficacy and safety of a novel dentifrice formulation immediately after the first supervised use and following one week of twice, daily use at home.

Timeline

Start
2023-01-30
Primary completion
2023-02-23
Completion
2023-02-23

Drugs

EvaluationDrugModalityDoseRoute
Subject NaF Unknown — —
Comparator NaF Unknown — —

Indications

No indication recorded.